Bullish & Foolish
Full SHPH fundamentals All 466 on the Survival Watch

SHPHSHUTTLE PHARMACEUTICALS HOLDINGS, INC.

Is Shuttle Pharmaceuticals Holdings struggling financially?

Yes, by its own account. Shuttle Pharmaceuticals Holdings told the SEC on 15 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$3.9M
Source filing
10-Q 15 May 2026
Balance sheet
31 Mar 2026

Cash runway

  • 0months

    If the burn speeds up

    Empty by Mar 2026

  • 1month

    If it eases off

    Empty by May 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$1.1M

÷

Cash burned over the last 12 months

$17.8M

What Shuttle Pharmaceuticals Holdings told the SEC

…and contingent payments due under the APA, and commercialize and market the Molecule.ai platform in order to generate revenues. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements do not include any…

SHUTTLE PHARMACEUTICALS HOLDINGS, INC., Form 10-Q, filed 15 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt